Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;84:1210-1215

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Binkley, P. F.
Right arrow Articles by Leier, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binkley, P. F.
Right arrow Articles by Leier, C. V.

Circulation, Vol 84, 1210-1215, Copyright © 1991 by American Heart Association


ARTICLES

Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function

PF Binkley, KD Murray, KM Watson, PD Myerowitz and CV Leier
Division of Cardiology, Ohio State University Hospital, Columbus 43210.

BACKGROUND. The synthetic catecholamine dobutamine increases stroke volume in normal subjects and in patients with congestive heart failure. In addition to its direct influence on myocardial contractility, dobutamine may significantly modulate vascular tone because of its alpha- and beta-adrenergic agonist activity. METHODS AND RESULTS. To test the hypothesis that such vasoactive properties significantly contribute to the improved ventricular performance noted with this agent, hemodynamic parameters were measured during stepped ascension infusion of dobutamine in a model that is insensitive to positive inotropic stimulation. Administration of dobutamine in nine calves that underwent replacement of the native right and left ventricles with pneumatically driven total artificial hearts resulted in a significant (p = 0.0001) increase in cardiac output from 7.0 +/- 1.8 to 8.2 +/- 1.8 l/min and a significant (p = 0.0001) decrease in total peripheral vascular resistance from 1,224 +/- 559 to 745 +/- 317 dyne.sec/cm5. A less marked influence was noted on the pulmonary vasculature, with pulmonary vascular resistance exhibiting a significant (p less than 0.05) decrease from its baseline value only at the peak infusion. Consistent with an increase in venous return, both left and right atrial pressures increased significantly (p less than 0.005) with dobutamine administration. CONCLUSIONS. These data demonstrate that the vasoactive properties of dobutamine significantly contribute to improved ventricular performance independent of direct myocardial stimulation. This effect appears to result in part from a direct modulation of myocardial stimulation. This effect appears to result in part from a direct modulation of arterial and venous tones rather than from a reflex response to primary changes in contractility.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Penny, J. P. Mynard, and J. J. Smolich
Aortic wave intensity analysis of ventricular-vascular interaction during incremental dobutamine infusion in adult sheep
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H481 - H489.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Uemura, A. Kamiya, I. Hidaka, T. Kawada, S. Shimizu, T. Shishido, M. Yoshizawa, M. Sugimachi, and K. Sunagawa
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure
J Appl Physiol, April 1, 2006; 100(4): 1278 - 1286.
[Abstract] [Full Text] [PDF]